From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
Parameters | Uveitis, yes n=32 | Uveitis, no n=143 | Ð |
---|---|---|---|
Onset age, years | 3.9 (2.1; 6.2) | 5.5 (2.5; 10.5) | 0.033 |
ANA positivity, n (%) | 15/26 (57.7) | 26/72 (36.1) | 0.056 |
Ongoing methotrexate, n (%) | 26 (81.3) | 103 (72.0) | 0.284 |
Time before 1st biologics, months | 2.9 (1.5; 5.3) | 2.2 (1.0; 5.2) | 0.343 |
Remission duration, months | 6.5 (2.4; 6.9) | 13.1 (6.5; 28.0) | 0.078 |
First significant flare, n (%) | 14 (43.8) | 24/142 (16.9) | 0.0009 |
Time before first significant flare, months | 33.0 (16.7; 61.5) | 48.6 (26.4; 65.7) | 0.023 |
Switching of the first biologic, n (%) | 7 (21.9) | 18/142 (12.7) | 0.180 |
Time before switching of the first biologics, months | 49.0 (24.5; 62.1) | 52.3 (35.0; 66.2) | 0.186 |